Key Points
- Omada Health CFO Steven Cook sold 1,108 shares at an average price of $25, generating $27,700 and reducing his ownership by 0.59%; he still owns 187,209 shares.
- Omada reported stronger-than-expected quarterly results, with EPS of $0.08 versus a consensus loss of $0.02 and revenue of $87.83 million versus estimates of $80.93 million.
- Analyst sentiment remains positive: 11 analysts rate the stock Buy, with an average price target of $26.50; Citizens JMP recently raised its target to $32, while the shares were trading near $24.55.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CFO Steven Cook sold 1,108 shares of Omada Health stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $25.00, for a total value of $27,700.00. Following the completion of the sale, the chief financial officer owned 187,209 shares of the company's stock, valued at approximately $4,680,225. The trade was a 0.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Omada Health Trading Up 3.6%
Omada Health stock opened at $24.55 on Tuesday. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The company has a market cap of $1.50 billion, a PE ratio of 491.00 and a beta of 1.73. The company's 50-day moving average is $22.41 and its two-hundred day moving average is $17.29.
Omada Health (NASDAQ:OMDA - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The company had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Research analysts forecast that Omada Health, Inc. will post 0.09 EPS for the current year.
Institutional Investors Weigh In On Omada Health
Several large investors have recently modified their holdings of OMDA. Geode Capital Management LLC acquired a new stake in shares of Omada Health during the second quarter worth about $637,000. Walleye Capital LLC acquired a new position in shares of Omada Health in the 2nd quarter valued at approximately $458,000. Ilex Capital Partners UK LLP bought a new stake in Omada Health during the 2nd quarter worth approximately $201,000. Soros Fund Management LLC bought a new stake in Omada Health during the 2nd quarter worth approximately $640,000. Finally, Raymond James Financial Inc. acquired a new stake in Omada Health during the 2nd quarter worth approximately $32,000.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on OMDA shares. Citizens Jmp increased their price target on Omada Health from $27.00 to $32.00 and gave the company a "market outperform" rating in a research note on Friday, August 14th. Wells Fargo & Company lifted their price objective on Omada Health from $17.00 to $18.00 and gave the stock an "equal weight" rating in a research note on Friday, May 8th. The Goldman Sachs Group reissued a "buy" rating on shares of Omada Health in a research note on Friday, May 8th. Citigroup restated an "outperform" rating on shares of Omada Health in a report on Friday, August 14th. Finally, Barclays boosted their target price on Omada Health from $20.00 to $25.00 and gave the stock an "overweight" rating in a research report on Monday, August 3rd. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Omada Health has an average rating of "Moderate Buy" and an average target price of $26.50.
View Our Latest Analysis on OMDA
About Omada Health
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
